Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BBS9 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | ABCB5 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | SUPV3L1 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | C19orf24 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | MSANTD3-TMEFF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
mRNA | NREP | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | ZFPM2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | SOX10 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-05 |
mRNA | FOXN3 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | APBB1 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |